HUP0003796A2 - Dexametazon gél - Google Patents

Dexametazon gél

Info

Publication number
HUP0003796A2
HUP0003796A2 HU0003796A HUP0003796A HUP0003796A2 HU P0003796 A2 HUP0003796 A2 HU P0003796A2 HU 0003796 A HU0003796 A HU 0003796A HU P0003796 A HUP0003796 A HU P0003796A HU P0003796 A2 HUP0003796 A2 HU P0003796A2
Authority
HU
Hungary
Prior art keywords
gel
dexamethasone
preparation
dexamethasone gel
consistency
Prior art date
Application number
HU0003796A
Other languages
English (en)
Inventor
Günther Bellmann
Gudrun Claus-Herz
Christoph Kessler
Original Assignee
Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh filed Critical Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
Publication of HUP0003796A2 publication Critical patent/HUP0003796A2/hu
Publication of HUP0003796A3 publication Critical patent/HUP0003796A3/hu
Publication of HU224986B1 publication Critical patent/HU224986B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

A találmány szemészeti készítményre vonatkozik, amely a szokásosadalékanyagok és víz mellett hatóanyagként dexametazont, ezenkívül atalálmány értelmében legalább egy farmakológiailag elfogadhatógélképző anyagot tartalmaz olyan mennyiségben, amely a készítménygélszerű konzisztenciájának biztosításához megfelelő viszkozitáshozszükséges. Ó
HU0003796A 1997-10-06 1998-10-05 Dexamethasone gel HU224986B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19744113A DE19744113A1 (de) 1997-10-06 1997-10-06 Dexamethason-Gel
PCT/EP1998/006339 WO1999017780A1 (de) 1997-10-06 1998-10-05 Dexamethason-gel

Publications (3)

Publication Number Publication Date
HUP0003796A2 true HUP0003796A2 (hu) 2001-04-28
HUP0003796A3 HUP0003796A3 (en) 2001-05-28
HU224986B1 HU224986B1 (en) 2006-05-29

Family

ID=7844743

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003796A HU224986B1 (en) 1997-10-06 1998-10-05 Dexamethasone gel

Country Status (18)

Country Link
EP (1) EP1021192B1 (hu)
JP (1) JP4156793B2 (hu)
KR (1) KR100392481B1 (hu)
CN (1) CN1142782C (hu)
AR (1) AR017170A1 (hu)
AT (1) ATE230601T1 (hu)
BR (1) BR9812849A (hu)
CA (1) CA2300806C (hu)
DE (2) DE19744113A1 (hu)
DK (1) DK1021192T3 (hu)
ES (1) ES2191352T3 (hu)
HK (1) HK1030748A1 (hu)
HU (1) HU224986B1 (hu)
IL (1) IL135001A0 (hu)
MX (1) MXPA00003363A (hu)
PL (1) PL189727B1 (hu)
WO (1) WO1999017780A1 (hu)
ZA (1) ZA989066B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808375A (en) 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
CN101190177B (zh) * 2006-11-24 2010-09-01 上海医药工业研究院 醋酸地塞米松局部成膜凝胶组合物及其应用
US20150190407A1 (en) * 2014-01-07 2015-07-09 Insite Vision Incorporated Methods for treatment of postoperative inflammation with reduced intraocular pressure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212392C3 (de) * 1972-03-15 1981-03-19 Avicon Inc., Fort Worth, Tex. Verwendung von mikrokristallinem Collagen zur Herstellung eines wäßrigen pharmazeutischen Mittels für die topische Anwendung am Auge
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
WO1995005803A1 (en) * 1993-08-20 1995-03-02 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
DE4404990C1 (de) * 1994-02-17 1995-05-04 Mann Gerhard Chem Pharm Fab Verfahren zur Herstellung eines sterilen Prednisolongels
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
EP1021192B1 (de) 2003-01-08
KR100392481B1 (ko) 2003-07-23
IL135001A0 (en) 2001-05-20
DE59806884D1 (en) 2003-02-13
DK1021192T3 (da) 2003-05-05
WO1999017780A1 (de) 1999-04-15
PL189727B1 (pl) 2005-09-30
ATE230601T1 (de) 2003-01-15
HU224986B1 (en) 2006-05-29
ES2191352T3 (es) 2003-09-01
JP2001518510A (ja) 2001-10-16
CA2300806A1 (en) 1999-04-15
HK1030748A1 (en) 2001-05-18
AR017170A1 (es) 2001-08-22
DE19744113A1 (de) 1999-04-15
MXPA00003363A (es) 2007-12-07
BR9812849A (pt) 2000-08-08
KR20010030939A (ko) 2001-04-16
HUP0003796A3 (en) 2001-05-28
PL341026A1 (en) 2001-03-26
ZA989066B (en) 1999-06-15
JP4156793B2 (ja) 2008-09-24
CN1142782C (zh) 2004-03-24
CA2300806C (en) 2004-02-03
CN1266369A (zh) 2000-09-13
WO1999017780A8 (de) 2000-01-27
EP1021192A1 (de) 2000-07-26

Similar Documents

Publication Publication Date Title
DK0733357T3 (da) Farmaceutiske formuleringer i form af en thixotrop gel
AU2962295A (en) Cannabinoid receptor antagonists
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
HUP9802556A1 (hu) Eljárás és készítmény kötőszöveti kapcsolódások gyógyítására és helyreállítására
HUP0000839A2 (hu) Ciklosporint és egy anionos felületaktív szert tartalmazó szilárd gyógyszerkészítmények és eljárás ezek előállítására
SE9504661D0 (sv) New compounds
HUP0302881A2 (hu) Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
LU88694I2 (fr) Timolol ou un sel pharmaceutuquement acceptable de celui-ci en particulier le maléate de timolol en combinaison avec une gomme gélifiante
IL114193A (en) Ophthalmic pharmaceutical compositions based on sodium alginate
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
HUP0300905A2 (hu) Poliszacharidot tartalmazó vízmentes izzadsággátló készítmény
BR9901782A (pt) Forma para dosagem de nefazodona.
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
PT902789E (pt) Derivados de androsteno
UA37263C2 (uk) Протруйник та спосіб протруювання насіння
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
NO993066L (no) Ny behandling for leddinflammasjon
HUP9700826A1 (hu) Peptikus fekély elleni gyógyászati készítmények
ATE213937T1 (de) Spezielle halofantrinhaltige zusammensetzungen
DK0727996T3 (da) Fendazolformuleringer
AU2001274374A1 (en) Matrix protein compositions for dentin regeneration
HUP0003796A2 (hu) Dexametazon gél
HUP0204417A2 (en) Oral ciprofloxacin-composition of controlled release